United States · FDA National Drug Code directory
Topiramate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 69097-124_71f493d9-3aaa-4b13-8057-012e96e11dbc
- Product NDC
- 69097-124
- Form
- TABLET
- Composition / generic term
- Topiramate
- Labeler
- Cipla USA Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20140612
- Source listing expiry
- 20261231
Source-listed ingredients
- TOPIRAMATE — 100 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 60 TABLET in 1 BOTTLE (69097-124-03) · 69097-124-03
- 500 TABLET in 1 BOTTLE (69097-124-12) · 69097-124-12
- 1000 TABLET in 1 BOTTLE (69097-124-15) · 69097-124-15
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →